Australia Endotoxin Testing Market, By Product Type (Endotoxin Detection Kits & Reagents, Instruments, Systems, and Software, Endotoxin Testing Services and Consumables & Accessories), Test Type (Limulus Amoebocyte Lysate (LAL) Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test and Recombinant C (RFC) Assay), Application (Pharmaceutical Manufacturing, Medical Device Manufacturing, Raw Materials Production and Packaging Manufacture), Method (Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, and Turbidimetric Endotoxin Test), Mode of Purchase (Large Group, Mid and Small Group and Individual), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), Academic Research Institute and Others) – Industry Trends and Forecast to 2030.
Australia Endotoxin Testing Market Analysis and Size
The rapidly increasing pharmaceutical and medical device industries are a major driver for the market's growth. The rising inclination towards outsourcing to contract manufacturing organizations for endotoxin testing and other contamination testing purposes has increased considerably in recent years. Public and regulatory concerns about product safety would also increase more use of endotoxin testing. High demand for R&D investments in the life sciences industry would also boost the market.
Data Bridge Market Research analyses a growth rate in the Australia endotoxin testing market in the forecast period 2023-2030. The expected CAGR of the endotoxin testing market tends to be around 9.8% in the mentioned forecast period. The market was valued at USD 20.57 million in 2022 and would grow to USD 43.46 million by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Australia Endotoxin Testing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2030
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Endotoxin Detection Kits & Reagents, Instruments, Systems, and Software, Endotoxin Testing Services and Consumables & Accessories), Test Type (Limulus Amoebocyte Lysate (LAL) Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test and Recombinant C (RFC) Assay), Application (Pharmaceutical Manufacturing, Medical Device Manufacturing, Raw Materials Production and Packaging Manufacture), Method (Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, and Turbidimetric Endotoxin Test), Mode of Purchase (Large Group, Mid and Small Group and Individual), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), Academic Research Institute and Others)
|
|
Market Players Covered
|
Eurofins Scientific (France), Thermo Fisher Scientific (U.S.), Pall Corporation. (U.S.), Lonza (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany), STERIS (U.K.), Société Générale de Surveillance SA (France), Sartorius AG (Germany), and GenScript (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Bacterial endotoxin testing (BET) is a crucial safety condition in the biomedical and pharmaceutical industries. Endotoxins can cause symptoms of septic shock, fever, and pyrogenic reaction if enough of them reach the patient's bloodstream. Identifying bacterial endotoxins is a major safety requirement in the biomedical and pharmaceutical industries. Endotoxin quality-control tests must obey the regulatory criteria laid down by the European and the U.S. Pharmacopeia and the U.S. FDA.
Australia Endotoxin Testing Market Dynamics
Drivers
- Increasing R&D Activities Associated with Endotoxin Testing
The increasing investments in research and development in the pharmaceutical and biotechnology industries lead to market growth. Pharmaceutical, biotech, and numerous drug manufacturing companies use tests such as pyrogen testing for the safe manufacturing and introduction of infection-free products into the market. For instance, major market players in the pharmaceuticals market named, AstraZeneca, Roche, and Merck have invested heavily in R&D activities in 2021. Roche invested about $13.5 billion, up by 14.3% from 2020. Thus, high investments in R&D by pharmaceutical companies boost market growth.
Opportunities
- Increasing Rate of Development of Advanced Tests
Several new endotoxin testing techniques, such as recombinant factor C assay and monocyte activation test, have been developed and commercially distributed on a large scale due to high technological development. The turbidimetric endotoxin test, also known as the kinetic chromogenic Limulus amebocyte lysate (LAL) assay, is widely used to quantitatively determine bacterial endotoxins in pharmaceutical products and medical devices. The Limulus amebocyte lysate (LAL) test is widely used for drugs and devices in the pharmaceutical and biotechnology industries. Thus, this boosts market growth.
- Increasing Product Launches Associated with Endotoxin Testing
Numerous product launches and agreements are initiated by the companies, accelerating market growth. For instance, Charles River Laboratories launched new solutions named EndoScan-V software platform and Celsis automated detection platform for the sterility to meet pharmaceuticals needs. This new product launched by the company has boosted the company's microbial solutions portfolio, which will increase sales and revenue in the future. Also, WuXi AppTec launched its new medical device laboratory testing center in Suzhou, China, to form a globally integrated medical device testing platform to serve medical device customers and offer endotoxin testing services in 2020. This creates more opportunities in the market.
Restraints/Challenges
- Stringent Regulations of Endotoxin Testing
There are many regulations associated with endotoxin testing methods that are stringent. These quality control tests are necessary to comply with certain regulations. For instance, ACell Inc., a Maryland-based medical device manufacturer, was found guilty on the charges related to MicroMatrix powder wound dressing product by the Department of Justice in 2019.
This endotoxin testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the endotoxin testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Australia Endotoxin Testing Market Scope
The endotoxin testing market is segmented based on product type, test type, application, method, mode of purchase, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Endotoxin Detection Kits & Reagents
- Instruments, Systems, and Software
- Endotoxin Testing Services
- Consumables & Accessories
Test Type
- Limulus Amoebocyte Lysate (LAL) Test
- Monocyte Activation Test (MAT)
- Rabbit Pyrogen Test and Recombinant C (RFC) Assay
Application
- Pharmaceutical Manufacturing
- Medical Device Manufacturing
- Raw Materials Production
- Packaging Manufacture
Method
- Gel Clot Endotoxin Test
- Chromogenic Endotoxin Test
- Turbidimetric Endotoxin Test
Mode of Purchase
- Large Group
- Mid and Small Group
- Individual
End-Users
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Contract Research Organization (CRO)
- Contract Manufacturing Organization (CMO)
- Academic Research Institute and Others
Competitive Landscape and Australia Endotoxin Testing Market Share Analysis
The endotoxin testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Australia presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to endotoxin testing market.
Key players operating in the endotoxin testing market include:
- Viatris Inc.(U.S.)
- Eurofins Scientific (France)
- Thermo Fisher Scientific (U.S.)
- Pall Corporation. (U.S.)
- Lonza (Switzerland)
- Charles River Laboratories (U.S.)
- Merck KGaA (Germany)
- STERIS (U.K.)
- Société Générale de Surveillance SA (France)
- Sartorius AG (Germany)
- GenScript (U.S.)
SKU-